基于“痰瘀虚”理论探讨小儿腺样体肥大  

Discussion on adenoidal hypertrophy in children based on the phlegm blood stasis and deficiency theory

作　　者：乔淑楠 张娅 李新阳 朱珊[2] Qiao Shu'nan

机构地区：[1]河南中医药大学,河南郑州450046 [2]河南省中医院,河南郑州450002

出　　处：《中医临床研究》2021年第26期112-115,共4页Clinical Journal Of Chinese Medicine

基　　金：河南省高等学校重点科研项目(19A360005)。

摘　　要：腺样体肥大是儿童常见难治性疾病之一。近年来,该病的发病率逐年升高,已经严重影响到儿童的身心健康发育及家庭生活质量。导师朱珊教授是全国第二代名老中医学术传承人,从医30余年,对该病有较为深刻的认识。基于小儿生理病理特点,朱师认为本病的发生发展与“痰瘀虚”理论密切相关,从而进一步阐述了该病的病因病机。临证中根据“痰瘀虚”理论指导本病的治法治则,为选方用药提供依据,同时注重辨证论治、标本兼治,以期提高中医药治疗小儿腺样体肥大的临床疗效。Adenoidal hypertrophy is one of the common refractory diseases in children.In recent years,the incidence of adenoidal hypertrophy in children has increased year by year,which has seriously affected the physical and mental development,and life quality of the patients.Professor Zhu Shan,has been a doctor for more than 30 years,and has a deep understanding on the disease.Based on the physiological and pathological characteristics of children,Mr.Zhu believes that the occurrence and development of the disease is closely related to the phlegm,blood stasis and deficiency theory,thus the etiology and pathogenesis of the disease is further expounded.In clinic,the phlegm,blood stasis and deficiency theory was applied to guide the treatment of adenoidal hypertrophy,and TCM syndrome differentiation and treatment was emphasized,in order to improve the clinical efficacy of traditional Chinese medicine in treating adenoidal hypertrophy in children.

关 键 词：小儿腺样体肥大 “痰瘀虚”理论 辨证论治 

分 类 号：R72[医药卫生—儿科]